Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of SUSTOL and CINVANTI. Its pipeline product is HTX-011.
| Website: | www.herontx.com |
| Email: | ir@herontx.com |
| Main Phone: | +1 858 251-4400 |
| Address: | 4242 Campus Point Court |
| Address 2: | Suite 200 |
| State: | CA |
| City / Town: | San Diego |
| Country: | US |
| Postal Code: | 92121 |
| Exchange: | NSC |
| CEO: | Barry D. Quart |
| Employees: | 231 |
| NAICS: | Pharmaceutical Preparation Manufacturing(325412) |
Significant reduction in pain intensity and opioid use in two separate study groups.
Showed reduced pain and reduced opioid medication use post surgery.
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of SUSTOL and CINVANTI. Its pipeline product is HTX-011.
| Website: | www.herontx.com |
| Email: | ir@herontx.com |
| Main Phone: | +1 858 251-4400 |
| Address: | 4242 Campus Point Court |
| Address 2: | Suite 200 |
| State: | CA |
| City / Town: | San Diego |
| Country: | US |
| Postal Code: | 92121 |
| Exchange: | NSC |
| CEO: | Barry D. Quart |
| Employees: | 231 |
| NAICS: | Pharmaceutical Preparation Manufacturing(325412) |
Significant reduction in pain intensity and opioid use in two separate study groups.
Showed reduced pain and reduced opioid medication use post surgery.
| Last Price 14.57 | Change $ -0.23 | Change % -1.55 | Tick N/A |
| Bid 14.00 | Bid Size 100.00 | Ask 16.48 | Ask Size 600.00 |
| Open 14.70 | High 14.87 | Low 14.27 | Prev Close 14.80 |
| Last Trade | Volume 691,040 | 52 Wk Hi 26.81 | 52 Wk Low 9.61 |
| Market Cap 1.3 bi | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares 90,855,254.00 | EPS (TTM) -2.25 | PE Ratio N/A | Exchange NCM |
|
|
|
|
| Last 3 Mo | Last 12 Mo | |
|---|---|---|
| Number of Insider Trades | 5 | 10 |
| Number of Buys | 3 | 6 |
| Number of Sells | 2 | 4 |
| Net Activity | 192308 | 192844 |
| Last 10 Buys | Shares |
|---|---|
| Kevin C. Tang | 1,000 |
| John W. Poyhonen | 1,000 |
| Kevin C. Tang | 1,000 |
| Kevin C. Tang | 1,000 |
| Kevin C. Tang | 1,000 |
| Kevin C. Tang | 1,000 |
| Kevin C. Tang | 1,000 |
| Kevin C. Tang | 1,000 |
| Barry D. Quart | 1,000 |
| Barry D. Quart | 1,000 |
| Last 10 Sell | Shares |
|---|---|
| Kimberly J. Manhard | 1,000 |
| Barry D. Quart | 1,000 |
| Barry D. Quart | 1,000 |
| Kimberly J. Manhard | 1,000 |
| Kimberly J. Manhard | 1,000 |
| Robert H. Rosen | 1,000 |
| Robert H. Rosen | 1,000 |
| Robert H. Rosen | 1,000 |
| Robert H. Rosen | 1,000 |
| Robert H. Rosen | 1,000 |
| Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
|---|---|---|---|---|
| High Target Price Estimate | 56 | 56 | 56 | 56 |
| Low Target Price Estimate | 30 | 30 | 30 | 30 |
| Mean Target Price Estimate | 39.91 | 39.91 | 39.91 | 39.91 |
| Standard Deviation | 9.01 | 9.01 | 9.01 | 9.01 |
| Date of Most Recent Estimate | 05/22/18 | 05/22/18 | 05/22/18 | 05/22/18 |
| Form Type | Form Description | Pages | Date |
|---|---|---|---|
| 10-Q | Quarterly report with a continuing view of a company's financial position | 83 | 2018-05-10 |
| 8-K | Report of unscheduled material events or corporate changes. | 9 | 2018-05-10 |
| DEFA14A | Additional proxy soliciting materials - definitive | 3 | 2018-04-30 |
| DEF 14A | Official notification to shareholders of matters to be brought to a vote (Proxy) | 56 | 2018-04-30 |
| PRE 14A | Preliminary proxy statement providing notification matters to be brought to a vote | 56 | 2018-04-19 |
| 8-K | Report of unscheduled material events or corporate changes. | 57 | 2018-04-03 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-04-02 |
| 424B5 | Prospectus filed under Rule 424(b)(5) | 45 | 2018-03-30 |
| 424B5 | Prospectus filed under Rule 424(b)(5) | 44 | 2018-03-28 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-03-19 |
| Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|
| Strong Buy | 10 | 10 | 10 | 8 |
| Moderate Buy | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Mean Rec. | 1.09 | 1.09 | 1.09 | 1.11 |
© 2020 Equities News | Equities.com, Inc.
* All dates and time are being displayed in Eastern Standard Time (EST).
Gathering Data... Please wait